Project Name: Rozšíření výzkumné a vývojové kapacity společnosti QUINTA-ANALYTICA, s.r.o.

Project Number: CZ.01.1.02/0.0/0.0/20_338/0023928

EUROPEAN UNION, European Regional Development Fund, OP Enterprise and Innovation for Competitiveness

The purpose of the project was to built a new research and development laboratory in Brno, which led to the expansion of the existing research and innovation capacity. In the frame of this significant project a top workplace equipped with the latest instruments and equipment for the analysis of medicinal products was created.

The research infrastructure is available to other users as a commercial service.

The list of the technologies offered for R&D purposes:

  • Liquid chromatograph 1260 + ELS detector
  • Liquid chromatograph 1260 + VW detector
  • H-Class Liquid Chromatograph
  • H-Class liquid chromatograph + RI detector
  • Agilent 8890 Gas Chromatograph with Mass Detector
  • GC/MS/MS Instrument
  • LCMS instrument with accessories
  • Fully automated dissolution system including UV spectrometer
  • Xtend on/offline with FS and SAM including spectrophotometer – UV7
  • Microbalances
  • Analytical balances
  • Hardness Tester, Disintegrator Tester
  • Centrifuge
  • Particle size analyser
  • Laminar box for particle sizer
  • Sleeve isolator
  • Oscillating Ball Mill
  • Fire-resistant chemical storage box
  • LIMS system

Further information are available upon request on robert.khaddour@quinta.cz.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.